Anthera Pharmaceuticals IncOver The Counter Market:ANTH
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | ANTH |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Anthera Pharmaceuticals Inc | 30.0 | 0.0x | --- |
VIA Pharmaceuticals Inc | 20.0 | 0.0x | --- |
OncoSec Medical Inc | 1.2K | 0.0x | --- |
Gene Biotherapeutics Inc | 60.0 | 0.0x | --- |
Allon Therapeutics Inc | 14.1K | 0.0x | --- |
Cell Source Inc | 7.7K | 0.0x | --- |
Company Information
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.
Contact Information
- Headquarters
- 25801 Industrial Boulevard, Suite BHAYWARD, CA, United States 94545
- Phone
- 510-856-5600
- Fax
- 510-856-5597
Executives
- Executive Chairman of the Board
- Paul Truex
- President, Chief Executive Officer, Director
- J. Craig Thompson
- Senior Vice President - Finance and Administration, Principal Accounting Officer
- May Liu
- Independent Director
- Brent Furse
- Independent Director
- Christopher Henney
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 26.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.69 |
Book Value | $-0.40 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
